|
|
||||||||
The Montreal General Hospital, Montreal, Quebec, Canada
Correspondence: For reprints contact: Leonard Rosenthall, Div. of Nuclear Medicine, The Montreal General Hospital, 1650 Cedar Avenue, Montreal 109, Quebec, Canada.
ABSTRACT
An assessment of the efficacy of 99mTc-polyphosphate (99mTcPP) in the disclosure of synovitis in 27 patients is presented. A comparison was made between 99mTcPP, clinical evaluation, 99mTcO4, and radiography. In general 99mTcPP was found to be more sensitive in the detection of inflammatory synovitis in peripheral joints than the other three methods, but it is also non-specific as increased periarticular accretions were found in degenerative osteoarthritis, metabolic bone disease, and trauma. Although 99mTcPP joint imaging qualifies as a screening procedure, regions of increased uptake should be radiographed to determine whether other causative factors exist.
This article has been cited by other articles:
![]() |
F. Jamar, F. A. Houssiau, J.-P. Devogelaer, P. T. Chapman, D. O. Haskard, V. Beaujean, C. Beckers, D.-H. Manicourt, and A. M. Peters Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis Rheumatology, January 1, 2002; 41(1): 53 - 61. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |